Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, November 18, 2013

Phase II Tac-HFT Trial Shows Excellent Safety Profile, Suggests...

BioCardiaA , Inc., a leader in cardiovascular regenerative medicine, today announced positive 12-month results for the randomized Transendocardial Autologous Cells in Ischemic Heart Failure Trial .

http://www.businesswire.com/news/topix/20131118005263/en
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts